AI assistant
Alembic Ltd — Annual Report 2021
May 11, 2021
61312_rns_2021-05-11_829f0ec2-9c29-47bc-96c8-3971c48c3387.pdf
Annual Report
Open in viewerOpens in your device viewer

Date: llth May, 2021
To I The Manager, Listing Department, National Stock Exchange of India Ltd Exchange Plaza, Bandra Kurla Complex, Bandra (E), Mumbai
Dear Sir,
Sub: Outcome of Board Meeting
With reference to the captioned subject, the exchange is hereby informed that the Board of Directors of Alembic Limited at its meeting held today has inter alia:
-
- Approved the Audited Financial Results of the Company for the financial year ended 31st March, 2021.
-
- Recommended Dividend of Rs. 0.20/- (10%) per Equity Share having face value of Rs. 2 each for the year ended 31st March, 2021, subject to approval of Shareholders at the ensuing Annual General Meeting.
We enclose the following :
A. (i) Consolidated Audited Financial Results for the quarter and financial year ended 31st March, 2021.
(ii) Consolidated Statement of Assets and Liabilities as at 31st March, 2021
(iii) Consolidated Cash Flow Statement for the financial year ended 31st March, 2021.
B. (i) Standalone Audited Financial Results for the quarter and financial year ended 31st March, 2021.
(ii) Standalone Statement of Assets and Liabilities as at 31st March, 2021
(iii) Standalone Cash Flow Statement for the financial year ended 31st March, 2021.
C. Auditor's Report on Consolidated and Standalone Financial Results.
A@# Lcr ~(; la(%dOdara)E
ALEMBIC LIMITED

We hereby declare that the Statutory Auditors of the Company, M/s. CNK & Associates LLP, Chartered Accountants has issued audit report with unmodified opinion on the Consolidated and Standalone Audited Financial Results of the Company for the financial year ended 31st March, 2021. This declaration is given in compliance with Regulation 33(3)(d) of SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015.
The time of commencement of the Board Meeting was 4:00 p.m. and the time of conclusion was 5: 15 p.m.
We request you to kindly take the same on record.
Thanking you.
Yours faithfully, Company Secretary
Encl.: A/a

ALEMBIC LIMITEDCIN:L26100GJ1907PLC000033Regd.Office: Alembic Road, Vadodara 390 003Ph:0265 2280550 www.alembiclimited.com Email:[email protected]
Statement of Consolidated Audited Financial Results for the Quarter and Year ended 31st March, 2021
| Rs. in Lakhs | |||||||
|---|---|---|---|---|---|---|---|
| Quarter Ended | Year Ended | ||||||
| Sr.No. | Particulars | 31.03.2021(Audited) | 31.12.2020(Unaudited) | 31.03.2020(Audited) | 31.03.2021(Audited) | 31.03.2020(Audited) | |
| 1 Revenue from Operations | 2,889 | 1,448 | 1,148 | 7,352 | 7,393 | ||
| 2 | Other Income | 177 | 302 | 5,727 | 1,027 | 9,340 | |
| 3 Total Income | 3,066 | 1,750 | 6,876 | 8,379 | 16,733 | ||
| 4 | Expenses | ||||||
| Cost of Materials ConsumedCost of Construction | 405 | 209 | 240 | 1,177 | 2,459 | ||
| Changes in Inventories of Finished Goods and WIP | 1,094 | 91 | $\mathbf{1}$ | 1,286 | 28 | ||
| Employee Benefit Expenses | (239) | (136) | (94) | (239) | 684 | ||
| Finance Costs | 5019 | 559 | 550 | 2,260 | 2,079 | ||
| Depreciation and amortisation expense | 103 | 10102 | 990 | 36394 | 29323 | ||
| Other Expenses | 733 | 335 | 517 | 1,761 | 1,815 | ||
| Total Expenses | 2,607 | 1,170 | 1,313 | 6,675 | 7,416 | ||
| 5 Profit Before Tax | 459 | 580 | 5,563 | 1,704 | 9,317 | ||
| 6 Tax Expenses | |||||||
| Current Tax | 93 | 94 | $\overline{\phantom{a}}$ | 290 | |||
| Deferred Tax | 7 | (1) | 16 | 35 | 28 | ||
| Short / (Excess) Provision of earlier years | (6) | ٠ | (6) | (15) | |||
| $\overline{\phantom{a}}$ | Net Profit after tax for the Period | 364 | 487 | 5,547 | 1,384 | 9,303 | |
| 8 | Share of Associate's Profit | 6,830 | 8,072 | 5,996 | 32,900 | 23,608 | |
| 9 Net Profit after tax and Share of Associate's Profit | 7,194 | 8,559 | 11,543 | 34,284 | 32,912 | ||
| 10 Other Comprehensive IncomeA (i) Items that will not be reclassified to Profit or Loss | 27,164 | (1,095) | |||||
| (ii) Income tax relating to items that will not be reclassified toProfit or Loss | (3, 124) | 130 | (4, 553)547 | 38,992(4, 452) | (2, 230)284 | ||
| B (i) Items that will be reclassified to Profit or Loss | 4 | (18) | 103 | (75) | 225 | ||
| 11 Total Comprehensive Income/(Loss) for the Period | 31,238 | 7,575 | 7,640 | 68,749 | 31,190 | ||
| 12 Paid up Equity Share Capital (Face Value of Rs 2/- per share) | 5,135.64 | 5,135.64 | 5,135.64 | 5,135.64 | 5,135.64 | ||
| 13 Other Equity (excluding Revaluation Reserve) | 1,80,277 | 1,26,948 | |||||
| 14 Earnings per equity share (FV Rs. 2/- per share)Basic & Diluted (In Rs.) | 2.80 | 3.33 | 4.50 | 13.35 | 12.82 |


Alembic Limited
Segment wise Consolidated Re anue and Peculte
| Sr. | Rs. In Lakhs | |||||
|---|---|---|---|---|---|---|
| No. | Particulars | Quarter Ended | Year Ended | |||
| 31.03.2021 | 31.12.2020 | 31.03.2020 | 31.03.2021 | 31.03.2020 | ||
| 1 | Segment Revenue | (Audited) | (Unaudited) | (Audited) | (Audited) | (Audited) |
| Revenue from Operations | ||||||
| a. Active Pharmaceutical Ingredients Business | 716 | 564 | 580 | 2,849 | ||
| b. Real Estate Business | 2,173 | 884 | 568 | 4,502 | 5,109 | |
| Total Income from Operations (Net) | 2,889 | 1,448 | 1,148 | 7,352 | 2,2847,393 | |
| $\overline{2}$ | Segment Results (Profit (+)/ Loss (-) before Taxes and interest from eachsegmenti | |||||
| a. Active Pharmaceutical Ingredients Business | (163) | 82 | (101) | (128) | 155 | |
| b. Real Estate Business | 571 | 336 | 22 | 1,312 | 218 | |
| Total | 408 | 418 | (79) | 1,184 | 373 | |
| Unallocable Income and Expenditure | ||||||
| (i) Interest Expense | (9) | (10) | (9) | (36) | (29) | |
| (ii) Dividend Income and Gain/(Loss) on Fair Value Change of Financial Asset | (89) | 61 | 5,608 | 115 | 8,847 | |
| (iii) Other Income / (Expense) | 150 | 111 | 44 | 442 | 125 | |
| Total Profit Before Tax | 459 | 580 | 5,563 | 1,704 | 9,317 | |
| 3 | Segment Assets | |||||
| a. Active Pharmaceutical Ingredients Business | 15,445 | 14,947 | 20,414 | 15,445 | 20,414 | |
| b. Real Estate Business | 21,494 | 17,263 | 13,399 | 21,494 | 13,399 | |
| c. Unallocated | 2,03,958 | 1,74,495 | 1,13,259 | 2,03,958 | 1,13,259 | |
| Total | 2,40,896 | 2,06,705 | 1,47,072 | 2,40,896 | 1,47,072 | |
| 4 | Segment Liabilities | |||||
| a. Active Pharmaceutical Ingredients Business | 1,712 | 1,730 | 1.577 | 1,712 | 1,577 | |
| b. Real Estate Business | 4,819 | 4.951 | 3,522 | 4,819 | 3,522 | |
| c. Unallocated | 4,663 | 1,560 | 169 | 4,663 | 169 | |
| Total | 11,193 | 8,241 | 5,268 | 11,193 | 5,268 |
Notes:
1 The above results have been audited by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company.
2 The Board has recommended Dividend on Equity Shares at Rs 0.20 per share (face value Rs. 2/- each) Le 10% for the year ended on 31st March, 2021 (Previous year Rs. 0.60 per share i.e 30%)
3 During the quarter ended 31st March 2021, due to resurgence of Covid-19, the Real Estate segment was adversely impacted with slow-down inConstruction activities, new residential bookings and rental activities. The API s
The Company's management has made an internal assessment and believes that the impact is likely to be short term in nature and does not foresee any medium to long term risk in company's ability to continue as a going concern.
4 The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year.
For Alembic Limited
Place: Dubai Date: 11th May, 2021

BICLIM Q m L. Vadodara A $\blacklozenge$
Udit Amin Director
| Statement of ConsoIIdated Assets and IIabiIItIes | Rs. In lakhs | |
|---|---|---|
| Particulars | As at 31st March,2021 | As at 31st March,2020 |
| IAudited; | (Audited | |
| ASsrrs | ||
| Non{urrent Assets | ||
| (a) Property, Plant and Equipments | 13.369 | 13,063 |
| (b) Capital Work-In-Progress | 584 | 308 |
| (c) Investment Property | 13.124 | 9.440 |
| (d) Goodwill | 5 | 5 |
| (e) Financial Assets | ||
| (i) Investrnents | 49,279 | 10.252 |
| (ii) Investments accounted using Equity Method | 1,53,779 | 97.636 |
| (iII) Loans | 110 | 86 |
| (Iv) Others | 352 | |
| (f) Other Non.Current Assets | 85 | |
| mm | M | |
| Current Assets | ||
| (a) Inventories | 5,428 | 3.541 |
| (b) Financial Assets | ||
| (i) Investments | 1,659 | 5,371 |
| (I1) Trade Receivables | 1,381 | 898 |
| (iII) Cash and Cash Equivalents | 589 | 5.830 |
| (iv) Bank Balances other than included in (II1) above | 69 | SS |
| (v) Loans | 6 | 6 |
| (vi) Others | 74 | |
| {c) Other Current Assets | 967 | 482 |
| (d) Current Tax Assets (Net) | 37 M | 98 |
| ME | ||
| TOTAL . ASSFrs | mm | |
| liZ4@6@ | ||
| EQurrY AND UABIUTIES | ||
| EquIty | ||
| {a) Equity Share Capital | 5,136 | 5.136 |
| (b) Other Equity | 2.24,567EjEna | 1,36.669aDam |
| liabiIItIes | ||
| Non£urrent LIabIIIties | ||
| (a) FInancial Uabilltles | ||
| (i) Other FInancial Liabilities | 506 | |
| (b) Provisions | 83 | |
| (c) Deferred Tax Liability (Net) | 4,663 | |
| E5EgE4 | ||
| Current LIabIlities | ||
| (a) FInancial Liabilities | ||
| (i) Borrowings | 28 | |
| (ii) Trade Payables | ||
| a) total outstanding dues of MIcro and Small Enterprises | 182 | 158 |
| b) total outstandIng dues of creditors other than MIcro and Small Enterprises | 1.599 | 1.140 |
| 386 | 438 | |
| (II1) Other FInancIal LIabiIItIes(b) Other Current Liabilities | 1,769 | |
| 2.680 | 1,074 | |
| (c) Provisions | 1,066Baa | |
| EMs@I | ||
| TOTAL - EQUITY AND LIABILrrIES | ,40,896 | 1,47,072 |
Place : Dubai Date : llth May, 2021

mblc LImited

\aT Udlt AmIn
DIrector
Alembic Limited
Consolidated Cash Flow Statement for Year ended 31st March, 2021
| Rs. In Lakhs | |||
|---|---|---|---|
| For the Year Ended For the Year Ended | |||
| Particulars | on 31st March, | on 31st March, | |
| 2021 | 2020 | ||
| A CASH FLOW FROM OPERATING ACTIVITIES: | |||
| Net Profit before tax | 1,704 | 9,317 | |
| Add: | |||
| Depreciation | 394 | 323 | |
| Interest charged | 36 | 29 | |
| (Gain) / Loss on sale of Property, Plant and Equipments | (24) | (51) | |
| Sundry balances written back (Net) | (41) | ||
| Other Non cash items | (78) | (60) | |
| Less: | |||
| Interest Income | (84) | (24) | |
| Dividend Income | (38) | (8,788) | |
| Operating Profit before change in working capital | 1,869 | 746 | |
| Working capital changes: | |||
| Add / (Less) : | |||
| (Increase) / Decrease in Inventories | (1, 887) | (9) | |
| (Increase) / Decrease in Trade Receivables | (483) | 452 | |
| (Increase) / Decrease in Other Asset | (485) | (40) | |
| (Increase) / Decrease in Financial Asset | (450) | (70) | |
| Increase / (Decrease) in Trade Payables | 523 | (1, 176) | |
| Increase / (Decrease) in Financial Liabilities | (7) | 134 | |
| Increase / (Decrease) in Other Liabilities | 911 | 1,295 | |
| Increase / (Decrease) in Provisions | 14 | (526) | |
| Cash generated from operations | 5 | 806 | |
| Add / (less): | |||
| Direct taxes paid (Net of refunds) | (223) | (153) | |
| Net cash inflow from operating activities (A) | (218) | 654 | |
| B | CASH FLOW FROM INVESTING ACTIVITIES: | ||
| Add: | |||
| Proceeds from sale of Property, Plant and Equipments | 25 | 62 | |
| Proceeds from sale / redemption of Investments | 19,549 | 4,970 | |
| Interest received | 84 | 24 | |
| Dividend received | 38 | 8.788 | |
| Less: | 19,696 | 13,843 | |
| Purchase of PPE and Investment Property/increase in CWIP and Capital Advances | 4,746 | 2,235 | |
| Purchase of Investments (Net) | 18,424 | 5,935 | |
| 23,169 | 8,171 | ||
| Net cash inflow from Investing activities (B) | (3, 474) | ||
| C CASH FLOW FROM FINANCING ACTIVITIES: | 5,672 | ||
| Add: | |||
| Net increase/(decrease) in working capital demand loansLess: | 28 | ||
| Dividends paid (including distribution tax) | |||
| Interest and other finance costs | 1.528 | 612 | |
| 36 | 29 | ||
| 1,564 | 641 | ||
| Net cash inflow from Financing activities © | (1, 536) | (641) | |
| l. Net (decrease) / Increase in cash and cash equivalents (A+B+C) | 5,685 | ||
| (5, 228) | |||
| II. Add: Cash and cash equivalents at the beginning of the period | 5,830 | 153 | |
| Other Bank Balances | 55 | 47 | |
| 5,885 | 201 | ||
| Ш. | Cash and cash equivalents at the end of the period | 589 | 5,830 |
| Other Bank Balances | 69 | 55 | |
| 657 | 5,885 | ||
| For Alembic Limited |

Place : DubaiDate : 11th May, 2021


ALEMBIC LIMITEDCIN:L26100GJ1907PLC000033Regd.Office: Alembic Road, Vadodara 390 003Ph:0265 2280550www.alembiclimited.com Email:[email protected]
Statement of Standalone Audited Financial Results for the Quarter and Year ended 31st March, 2021
| Rs. in Lakhs | ||||||
|---|---|---|---|---|---|---|
| Quarter Ended | Year Ended | |||||
| Sr. | ||||||
| No. | Particulars | 31.03.2021 | 31.12.2020 | 31.03.2020 | 31.03.2021 | 31.03.2020 |
| (Audited) | (Unaudited) | (Audited) | (Audited) | (Audited) | ||
| 1 Revenue from Operations | 2,854 | 1,418 | 1,136 | 7,230 | 7,369 | |
| $\overline{\mathbf{z}}$ | Other Income | 172 | 274 | 5,729 | 997 | 9,347 |
| з | Total Income | 3,026 | 1,692 | 6,865 | 8,227 | 16,716 |
| 4 | Expenses | |||||
| Cost of Materials Consumed | 405 | 209 | 240 | 1,177 | 2,459 | |
| Cost of Construction | 1,094 | 91 | 1 | 1,286 | 28 | |
| Changes in Inventories of Finished Goods and WIP | (239) | (136) | (94) | (239) | 684 | |
| Employee Benefit Expenses | 501 | 559 | 550 | 2,260 | 2,079 | |
| Finance Costs | 7 | 8 | 8 | 27 | 28 | |
| Depreciation and amortisation expense | 100 | 102 | 90 | 391 | 323 | |
| Other Expenses | 705 | 317 | 508 | 1,673 | 1,748 | |
| Total Expenses | 2,573 | 1,149 | 1,303 | 6,575 | 7,348 | |
| 5 Profit Before Tax | 453 | 543 | 5,562 | 1,652 | 9,368 | |
| 6 Tax Expenses | ||||||
| Current Tax | 93 | 94 | 290 | |||
| Deferred Tax | 3 | (1) | 16 | 31 | 28 | |
| Short / (Excess) Provision of earlier years | (6) | (6) | (15) | |||
| 7 | Net Profit after tax for the Period | 363 | 450 | 5,546 | 1,336 | 9,355 |
| 8 Other Comprehensive Income | ||||||
| (i) Items that will not be reclassified to Profit or Loss | 27,003 | (1, 112) | (4, 336) | 39,035 | (1,894) | |
| (ii) Income tax relating to items that will not be reclassified to | ||||||
| Profit or Loss | (3,096) | 133 | 510 | (4, 458) | 226 | |
| 9 Total Comprehensive Income/(Loss) for the Period | 24,270 | (530) | 1,719 | 35,913 | 7,687 | |
| 10 Paid up Equity Share Capital (Face Value of Rs 2/- per share) | 5,135.64 | 5,135.64 | 5,135.64 | 5,135.64 | 5,135.64 | |
| 11 Other Equity (excluding Revaluation Reserve) | 33,256 | 33,454 | ||||
| 12 Earnings per equity share (FV Rs. 2/- per share) | 0.14 | 0.18 | 2.16 | 0.52 | 3.64 | |
| Basic & Diluted (In Rs.) | ||||||


Alembic Limited
| Segment wise Standalone Revenue and Results | Rs. in Lakhs | |||||
|---|---|---|---|---|---|---|
| Sr. | Quarter Ended | Year Ended | ||||
| No. | Particulars | 31.03.2021 | 31.12.2020 | 31.03.2020 | 31.03.2021 | 31.03.2020 |
| (Audited) | (Unaudited) | (Audited) | (Audited) | (Audited) | ||
| $\mathbf{1}$ | Segment Revenue | |||||
| Revenue from Operations | ||||||
| a. Active Pharmaceutical Ingredients Business | 716 | 564 | 580 | 2,849 | 5,109 | |
| b. Real Estate Business | 2,138 | 854 | 556 | 4.381 | 2,260 | |
| Total Income from Operations (Net) | 2,854 | 1,418 | 1,136 | 7,230 | 7,369 | |
| $\overline{2}$ | Segment Results (Profit (+)/ Loss (-) before Taxes and interest from each | |||||
| segment) | ||||||
| a. Active Pharmaceutical Ingredients Business | (163) | 82 | (101) | (128) | 155 | |
| b. Real Estate Business | 562 | 296 | 20 | 1,250 | 269 | |
| Total | 399 | 378 | (81) | 1,122 | 424 | |
| Unallocable Income and Expenditure | ||||||
| (i) Interest Expense | (7) | (8) | (8) | (27) | (28) | |
| (ii) Dividend Income and Gain/(Loss) on Fair Value Change of Financial Asset | (89) | 61 | 5,607 | 115 | 8,847 | |
| (iii) Other Income / (Expense) | 150 | 111 | 44 | 442 | 125 | |
| Total Profit Before Tax | 453 | 543 | 5,562 | 1,652 | 9,368 | |
| 3 | Segment Assets | |||||
| a. Active Pharmaceutical Ingredients Business | 15,445 | 14,947 | 20,414 | 15,445 | 20,414 | |
| b. Real Estate Business | 20,284 | 16,651 | 13,288 | 20.284 | 13,288 | |
| c. Unallocated | 57,917 | 34,825 | 19,725 | 57,917 | 19,725 | |
| Total | 93,645 | 66,423 | 53,428 | 93,645 | 53,428 | |
| 4 | Segment Liabilities | |||||
| a. Active Pharmaceutical Ingredients Business | 1,712 | 1,730 | 1,577 | 1.712 | 1,577 | |
| b. Real Estate Business | 4,594 | 4.721 | 3.372 | 4,594 | 3,372 | |
| c. Unallocated | 4,658 | 1,560 | 169 | 4,658 | 169 | |
| Total | 10.963 | 8,011 | 5,118 | 10,963 | 5,118 |
Notes:
1 The above results have been audited by Statutory Auditors, recommended by Audit Committee and approved by the Board of Directors of the Company.
2 The Board has recommended Dividend on Equity Shares at Rs 0.20 per share (face value Rs. 2/- each) i.e 10% for the year ended on 31st March, 2021 (Previous year Rs. 0.60 per share i.e 30%)
3 During the quarter ended 31st March 2021, due to resurgence of Covid-19, the Real Estate segment was adversely impacted with slow-down in construction activities, new residential bookings and rental activities. The API segment, being a part of essential services is largely unaffected.
The Company's management has made an Internal assessment and believes that the impact is likely to be short term in nature and does notforesee any medium to long term risk in company's ability to continue as a going conce
4 The previous quarter's / year's figures have been regrouped / rearranged wherever necessary to make it comparable with the current quarter / year.
Place : Dubai Date: 11th May, 2021

Udit Amin Director
For Alembic Limited

| Statement of Standalone Assets and LIabilities | |||
|---|---|---|---|
| As at 31st March, | As at 3:Ist March, | ||
| Particulars | 2021 | 2020 | |
| {Audited] | [Audited | ||
| ASSETS | |||
| Non.Current Assets | |||
| (a) PropertY, Plant and Equipments | 13,369 | 13,063 | |
| (b) Capital Work-in-Progress | 584 | 308 | |
| (c) Investment Property | 12,744 | 9,440 | |
| (d) FInancial Assets | |||
| {i) Investments | 56,550 | 14,358 | |
| (ii) Others | 352 | ||
| (e) Other Non-Current Assets | 85 | ||
| Em | M | ||
| Current Assets | |||
| (a) Inventories | 5,428 | 3.541 | |
| (b) FInancIal Assets | |||
| (i) investments | 1,568 | 5,371 | |
| (Ii) Trade Receivables | 1,310 | 889 | |
| (II1) Cash and Cash Equivalents | 578 | 5,730 | |
| (iv) Bank Balances other than Included in (iii) above | 69 | 55 | |
| (V) Loans | 6 | 106 | |
| (vi) Others | 74 | ||
| (c) Other Current Assets | 925 | 471 | |
| (d) Current Tax Assets (Net) | 5 | ||
| aaa | 94 M | ||
| TOTAL . ASSETS | |||
| W3 | W3 | ||
| EQUITY AND LIABILITIES | |||
| EquIty | |||
| (a) Equity Share Capital | 5,136 | 5,136 | |
| (b) Other Equity | |||
| 77,546 | 43,174 | ||
| LiabIlities | W2 | a8 | |
| Non-Current LIabIIItIes | |||
| (a) Financial Liabilities | |||
| 384 | |||
| (i) Other Financial Liabilities(b) Provisions | 83 | ||
| (c) Deferred Tax Liability (Net) | 4,658 | ||
| Current LIabilities | 5,125 | ||
| (a) FInancIal Liabilities | |||
| 28 | |||
| (i) BorrowIngs(ii) Trade Payables | |||
| a) total outstandIng dues of MIcro and Small EnterprIses | 163 | 158 | |
| b) total outstanding dues of creditors other than Micro and Small Enterprises | 1,571 | 1,140 | |
| (iii) Other Financial LIabilities | 346 | 397 | |
| (b) Other Current Liabilities | 2,665 | 1,761 | |
| (c) Provisions | 1,066 | 1,074 mIl | |
| BEa | |||
| TOTAL . EQUITY AND LIABILITIES | 93,645 | aBU |
Alemblc LImIted
Place :DubaI

For Alembic LImited

| Rs. In lakhs | ||
|---|---|---|
| For the Year | For the Year | |
| Particulars | Ended on 31st | Ended on 31st |
| March, 2021 | March, 2020 | |
| Net Pro6t before tax | 1.652 | 9,368 |
| Add: | ||
| DeprecIatIon | 391 | 323 |
| Interest charged | 27 | 28 |
| (Gain) / Loss on sale of Property, Plant and EquIpments | (24)1 | (51) |
| Sundry balances written back (Net)Other Non cash items | (41) | |
| Less: | (77)1 | (60) |
| Interest Income | ||
| DivIdend Income | (83) | (30)(8.788] |
| OperatIng ProfIt before change in workIng capItal | 1381 M | 791 |
| Working capItal changes: | ||
| Add / (Ias) : | ||
| (Increase) / Decrease in Inventories | (lf887) | (9) |
| (Increase) / Decrease in Trade Recelvables | (421) | 461 |
| (Increase) / Decrease in Other Asset | (454) | (40) |
| (Increase) / Decrease in FInancial Asset | (326) | (84) |
| Increase / (Decrease) in Trade Payables | 477 | (1.176) |
| Increase / (Decrease) in FInancIal Uablllties | (8) | |
| Increase / (Decrease) in Other liabilities | 904 | 1,287 |
| Increase / (Decrease) in Provisions | 14 | (526) |
| Cash generated from operatIons | 84 | ImEI |
| Add / (Less) : | ||
| Direct taxes paid (Net of refunds) | (195] | (149) |
| Net cash Inflow from operatIng activities (A) | :111: | 548 |
| B CASH FLOW FROM iNVEsriNG AcrrviTiEs: | ||
| Add: | ||
| Proceeds from sale of Property, Plant and Equipments | 25 | 62 |
| Proceeds from sale / redemption of Investments | 19.474 | 4,970 |
| Interest receIved | 83 | 30 |
| Dividend received | 38 | 8,788 |
| less: | 19,620 | EIBIiEb] |
| Purchase of PPE and Investment Property/Increase in CWIP and Capital Advances | 4.363 | 2.235 |
| Purchase of Investments (Net) | 5.935 | |
| E8,171 | ||
| Net cash Inflow from InvestIng activItIes (B) | MEI | |
| IcCASH FLOW FROM FINANCING AcrlvmEs: | ||
| a1 d : | ||
| Net increasd'{decrease) in working capItal demand loans | 28 | |
| Less: | ||
| Dividends paid (Including distribution tax) | 1,528 | 612 |
| Interest and other finance costs | 27 | 28 |
| 640 | ||
| 527 | tRIll) | |
| Net cash Inflow from FInancIng actIvItIes.(C) | LI[ | =IIB |
| 1. Net (deaease) / Increase in cash and ash equIvalents (A+B+C) | E5Xll4%i | S,587 |
| II. Add: Cash and cash equIvalents at the begInnIng of the perIod | ||
| Other Bank Balances | ||
| Cash and cash equivalents at the end of the period111. | ||
| Other Bank Balances | ||
Alemblc LImIted
Standalone Cash Flow Statement for Year ended 31st March, 2021
Place : DubaI Date : lab May, 2021


For Alembic LimIted
CNK & Associates LLP
Chartered Accountantg
Narain Chambers, 5th Floor, M. G. Road1 Vile Parle (E)1 Mumbai . 400 057 rd.: + 9] -22-62507600
Alj't'y Bh,",", 3'd Fl..', Di";h," V.'bha Rod, Church#te, >t",.b,i- 4titl 02t) reI,: + 91 22 66230600
Independent Auditor's Report on the consolidated financial results of Alembic Limited pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended.
TO THE BOARD OF DIRECTORS OF ALEMBIC LIMITED
Report on the Audit of Consolidated Financial Results
Opinion
We have audited the accompanying statement of consolidated financial results of Alembic Limited (hereinafter referred to as the 'Holding Company") and its subsidiary (Holding Company and its subsidiary together referred to as "the Group"), and its associate for the year ended 31'L March, 2021, attached hcrewith, being submitted by the Holding Company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ('Listing Regulations') .
In our opinion and to the best of our information and according to the explanations given to us and based on the consideration of reports of other auditors on separate audited financial statements /financial results/ financial information of the subsidiary and associdte, the aforesaid consolidated financial results:
- a. includes results of the following entities:
- (i) Alcmbic City Limited (Subsidiary)
- (ii) Alembic Pharmaceuticals Limited (Associate)
- b. are presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard;
- c. give a true and fair view in conformity with applicable accounting standards, and other accounting principles generally accepted in India, of the consolidated net profit and other comprehensive income and other financial information of the Group for the year ended 31 't March, 2021
Basis of Opinion
We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Companies Act, 2013, as amended (" Act"). Our responsibilities under those SAs are further described in the Auditor's for the Audit of the Consolidated Financial Results section of our

report. We are independent of the Group and its associate in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the financial statements under the provisions of the Companies Act, 2013 and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence obtained by us and other auditors in terms of their reports referred to in "Other Matter" paragraph below, is sufficient and appropriate to provide a basis for our oplruon.
Board of Directors' Responsibilities for the Consolidated Financial Results
These consolidated financial results have been prcpdred on the basis of the consolidated financial statements. The Holding Company's Board of Directors are responsible for the preparation and presentation of these consolidated financial results that give a true and fair view of the consolidated net profit and other comprehensive income and other financial information of the Group including its associate in accordance with applicable accounting Stand,nds prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing Regulations. The respective Board of Directors of the companies included in the Group and of its associate are responsible for maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding of the assets of the Group and its associate and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and the design, implementation and maintenance of adequate internal financial controls, that were operating effectively for ensuring acLuracy and completeness of the accounting records, relevant to the preparation and presentation of the consolidated financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error, which have been used for the purpose of preparation of the consolidated financial results by the Directors of the Holding Company, as aforesaid
In preparing the consolidated financial results, the respective Board of Directors of the companies included in the Group and of its associate are responsible for assessing the ability of the Group and its associate to continue as a going concern, disclosing, as applicable, matters related to going concern and using the guing concern basis of accounting unless the respective Board of Directors either intends to liquidate the Group or to cease operations, or has no redlistic alternative but to do so.
The respective Board of Directors of the companies included in the Group and of its associate are responsible for overseeing the financial reporting process of the Group and of its associate

Auditor's Responsibilities for the Audit of the Consolidated Financial Results
Our objectives are to obtain reasonable assurance about whether the consolidated financial results as a whole are free from material rnisstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial results.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:
- Identify and assess the risks of material misstatement of the consolidated financial results, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3) (i) of the Act, we are also responsible for expressing our opinion whether the company has adequate internal financial controls with reference to financial statements in place and the operating effectiveness of such controls.
- Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by the Board of Directors.
- Conclude on the appropriateness of the Board of Directors use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the ability of the Group and its associate to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the consolidated financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Group and its associate to cease to continue as a go111g concern

- Evaluate the overall presentation, structure and content of the consolidated financial results, including the disclosures, and whether the consolidated financial results represent the underlying transactions and events in a manner that achieves fair presentation.
- Obtain sufficient appropriate audit evidence regarding the financial results/financial information of the Group and its associate to express an opinion on Consolidated Financial Results. We are responsible for the direction, supervision and performance of the audit of financial information of such entities included in the consolidated financial results of which we are the independent auditors. For the other entitIes included in the Consolidated Financial Results, which have been audited by other auditors, such other auditors remain responsible for the direction, supervision and performance of the audits carried out by them, We remain solely responsible for our audit opInIon.
We communicate with those charged with governance of the Holding Company and such other entities included in the consolidated financial results of which we are the independent auditors regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit
We also provide those charged with governance with a statementhat we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.
We also performed procedures in accordance with the circular issued by the SEBI under Regulation 33(8) of the Listing Regulations, as amended, to the extent applicable.
Other Matters
I The accompanying consolidated financial results include audited Financial Statements of one subsidiary which reflect total assets of Rs. 3,121.91 Lakhs as at 31't March 2021, total revenues of Rs. 500.33 Lakhs, totdl loss after tax of Rs. 56.67 Ldkh5, total comprehensive loss of Rs. 55.69 Lakhs and net cash outflows of Rs. 88.50 Lakhs for the year then ended, which have been audited by other auditor whose financial statements, other financial information and auditor's report have been furnished to us by the management. Our opinion on the consolidated financial statements, in so far as it relates to the amounts and disclosures included in respect of this subsidiary is based solely on the report of such other auditor and the procedures performed by us are as stated in paragraph above,

2, The accompanying consolidated financial results include the Group's share of Total Comprehensive Income (comprising of net profit after tax and other comprehensive income) of Rs. 32,788.20 Lakhs for the year ended on that date, in respect of 1 associate, which have been audited by other auditor, whose financial statements, other financial information and auditor's report have been furnished to us by the management. Our opinion on the consolidated financial statements, in so far as it relates to the amounts and disclosures included in respect of this associate is based solely on the report of such other auditor and the procedures performed by us are as stated in paragraph above.
Our opinion on the Consolidated Financial Results is not modified in respect of the above matters with respect to our reliance on the work done and the reports of the other auditors and the Financial Results/financial information certified by the Board of Directors.
- The Consolidated Financial Results includes the results for the quarter ended 31=t March, 2021 being the balancing figure between the audited figures in respect of the full financial year and the published unaudited year to date figures up to the third quarter of the current financial year which were subject to limited review by us.
For CNK & Associates LLP Chartered Accountants Firm Registration No. 101961W/W-100036
4§W%el C) t MUMBAI %*.f#; Himanshu Kishnadwaia
Partner Membership No,037391 Place: Mumbai Date: 11th May, 2021 UDTN: 21037391AAAACB8849
CNIK & Associates LLP
Chartered Accountants
Narain Chambers, 5th Floor, M. G. Road, Vile Parle (E), Mumbai - IOO 057. Tel,: + 91 -22-62507600
listry Bhavan. 3rd Floor, Din,h,w V,,hh, R,d, Ch."hg,t,, .\r","b,i- +t)O 020. Tel.: + 91 22 66230600
Independent Auditor's Report on Audited standalone Quarterly Financial Results and Year to Date Results of the Alembic Limited Pursuant to the Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended
TO THE BOARD OF DIRECTORS OF ALEMBIC LIMITED
Report on the audit of the Standalone Financial Results
Opinion
We have audited the accompanying statement of standalone financial results of Alembic Limited (the company) for quarter and year ended 31" March, 2021 (the "Statement"), attached herewith, being submitted by the company pursuant to the requirement of Regulation 33 of the Securities and Exchange Board of India (SEBI) (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended ("Listing Regulations" ).
In our opinion and to the best of our information and according to the explanations given to us, the statement:
- i. is presented in accordance with the requirements of Regulation 33 of the Listing Regulations in this regard; and
-
- give a true and fair view in conformity with the recof'nition and measurement principles laid down in the applicable Indian accounting standards and other accounting principles generally accepted in India of the net profit and other comprehensive income and other financial information for the quarter and year ended 31" March, 2021.
Basis of Opinion
We conducted our audit in accordance with the Standards on Auditing (SAs) specified under section 143(10) of the Companies Act, 2013, as amended ("the Act"). Our responsibilities under those SAs are further described in the " Auditor's Responsibilities for the Audit of the Standalone Financial Results" sectIon of our report. We are independent of the Company, in accordance with the Code of Ethics issued by the Institute of Chartered Accountants of India together with the ethical requirements that are relevant to our audit of the standalone financial results under the provisions of the Act and the Rules thereunder, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the Code of Ethics. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion

Management's Responsibilities for the Standalone Financial Results
The statement has been prepared on the basis of the standalone financial statements. The Company's Board of Directors are responsible for the preparation and presentation of these standalone financial results that give a true and fair view of the net profit and other comprehensive income and other financial information in accordance with the recognition and measurement principles laid down in Indian Accounting Standards prescribed under Section 133 of the Act read with relevant rules issued thereunder and other accounting principles generally accepted in India and in compliance with Regulation 33 of the Listing RegulatIons. This responsibility also includes maintenance of adequate accounting records in accordance with the provisions of the Act for safeguarding ofthe assets of the Company and for preventing and detecting frauds and other irregularities; selection and application of appropriate accounting policies; making judgments and estimates that are reasonable and prudent; and design, implementation and maintenance of adequate internal financial controls that were operating effectively for ensuring the accuracy and completeness of the accounting records, relevant to the preparation and presentation of the standalone financial results that give a true and fair view and are free from material misstatement, whether due to fraud or error
In preparing the standalone financial results, the Board of Directors are responsible for assessing the Company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the Board of Directors either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.
The Board of Directors are also responsible for overseeing the Company's financial reporting process.
Auditor/s Responsibilities for the Audit of the Standalone Financial Results
Our objectives are to obtain reasonable assurance about whether the standalone financial results as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with SAs will always detect a material misstaLement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these standalone financial results.
As part of an audit in accordance with SAs, we exercise professional judgment and maintain professional skepticisnr throughout the audit. We also:
• Identify and assess the risks of material misstatement of the standalone financial results, whether due to fraud or error, design and perform audit

procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.
- Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances. Under Section 143(3)(i) of the Act, we are also responsible for expressing our opinion through a separate report on the complete set of standalone financial statements on whether the company has adequate internal financial controls with reference to standalone financial statements in place and the operating effectiveness of such controls.
- Evaluate the appropTiateness of accounting policies used and the reasonableness of accounting estimates and related disclosures in the standalone financial results made by the Board of Directors.
- Conclude on the appropriateness of the Board of Directors' use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company's ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor's report to the related disclosures in the standalone financial results or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor's report. However, future events or conditions may cause the Company to cease to continue as a going concern.
- Evaluate the overall presentation, structure and content of the standalone financial results, including the disclosures, and whether the standalone financial results represent the underlying transactIons and events in a manner that achieves fair presentation.
We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit
We also provide those charged with governance with a stateme'nt that we have complied with relevant ethical requirements regarding independence. and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

Other matter
The Statement includes the results for the quarter ended 31st March, 2021 being the balancing figures between the audited figures in respect of full financial year ended 31=t march, 2021 and the published unaudited year to date figures up to the third quarter of the current financial year, which were subjected to a limited review by us, as required under the Listing Regulations.
t
%a
For CNK & Associates LLP Chartered Accountants Firm Registration No. 101961W/ W-100036
MUMBAI 1< t
Himanshu Kishnadwala Partner Membership No.037391 Place: Mumbai Date: lltl' May, 202-1 UDIN: 21037391AAAACA8633